Evidence map›Paper›PMID 25805998›Full record

ArticleFrontiers in physiology2015

Differential effects of buffer pH on Ca(2+)-induced ROS emission with inhibited mitochondrial complexes I and III.

Daniel P Lindsay, Amadou K S Camara, David F Stowe, Ryan Lubbe, Mohammed Aldakkak

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Mitochondrial Permeability Transition in Stem Cells, Development, and Disease.Advances in experimental medicine and biology · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Daniel P LindsayDepartment of Anesthesiology, The Medical College of Wisconsin Milwaukee, WI, USA.
Amadou K S CamaraDepartment of Anesthesiology, The Medical College of Wisconsin Milwaukee, WI, USA ; Cardiovascular Research Center, The Medical College of Wisconsin Milwaukee, WI, USA.
David F StoweDepartment of Anesthesiology, The Medical College of Wisconsin Milwaukee, WI, USA ; Cardiovascular Research Center, The Medical College of Wisconsin Milwaukee, WI, USA ; Department of Physiology, The Medical College of Wisconsin Milwaukee, WI, USA ; Department of Anesthesiology, VA Medical Center Research Service Milwaukee, WI, USA ; Department of Biomedical Engineering, Marquette University Milwaukee, WI, USA.
Ryan LubbeDepartment of Anesthesiology, The Medical College of Wisconsin Milwaukee, WI, USA.
Mohammed AldakkakDepartment of Anesthesiology, The Medical College of Wisconsin Milwaukee, WI, USA.
Medical College of Wisconsin · US

Funding

Stem Cell CoreP01GM066730 · NIGMS · MEDICAL COLLEGE OF WISCONSIN · PI DASH, RANJAN K · 2003 to 2019
$23.6M
Cations and ROS in Modulating Mitochondrial Function in Normal and Ischemic HeartR01HL095122 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI CAMARA, AMADOU K., DASH, RANJAN K · 2010 to 2013
$2.1M
Mitochondrial Ca-sensitive K channel-induced superoxide and cardiac protectionR01HL089514 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI STOWE, DAVID F · 2009 to 2012
$1.4M
NHLBI NIH HHS R01 HL089514NHLBI NIH HHS R01 HL095122NIGMS NIH HHS P01 GM066730
6 · The paper itself

Abstract

Excessive mitochondrial reactive oxygen species (ROS) emission is a critical component in the etiology of ischemic injury. Complex I and complex III of the electron transport chain are considered the primary sources of ROS emission during cardiac ischemia and reperfusion (IR) injury. Several factors modulate ischemic ROS emission, such as an increase in extra-matrix Ca(2+), a decrease in extra-matrix pH, and a change in substrate utilization. Here we examined the combined effects of these factors on ROS emission from respiratory complexes I and III under conditions of simulated IR injury. Guinea pig heart mitochondria were suspended in experimental buffer at a given pH and incubated with or without CaCl2. Mitochondria were then treated with either pyruvate, a complex I substrate, followed by rotenone, a complex I inhibitor, or succinate, a complex II substrate, followed by antimycin A, a complex III inhibitor. H2O2 release rate and matrix volume were compared with and without adding CaCl2 and at pH 7.15, 6.9, or 6.5 with pyruvate + rotenone or succinate + antimycin A to simulate conditions that may occur during in vivo cardiac IR injury. We found a large increase in H2O2 release with high [CaCl2] and pyruvate + rotenone at pH 6.9, but not at pHs 7.15 or 6.5. Large increases in H2O2 release rate also occurred at each pH with high [CaCl2] and succinate + antimycin A, with the highest levels observed at pH 7.15. The increases in H2O2 release were associated with significant mitochondrial swelling, and both H2O2 release and swelling were abolished by cyclosporine A, a desensitizer of the mitochondrial permeability transition pore (mPTP). These results indicate that ROS production by complex I and by complex III is differently affected by buffer pH and Ca(2+) loading with mPTP opening. The study suggests that changes in the levels of cytosolic Ca(2+) and pH during IR alter the relative amounts of ROS produced at mitochondrial respiratory complex I and complex III.

Indexed as

Ca2+mitochondrial complex Imitochondrial complex IIImitochondrial permeability transition porepHreactive oxygen speciessimulated ischemia

Identifiers

PMID25805998
PMCPMC4354303
OpenAlexW2004803969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.